Long-Term Mortality after Transsphenoidal Surgery and Adjunctive Therapy for Acromegaly<sup>1</sup>
Brooke Swearingen(Massachusetts General Hospital), Nicholas T. Zervas, Peter McL. Black, Nicole Moayeri, Laurence Katznelson(Stanford University), Fred G. Barker(Harvard University), Anne Klibanski(Mass General Brigham), Beverly M. K. Biller(Massachusetts General Hospital), Steven Grinspoon(Massachusetts General Hospital)
Cited by 587
Related Papers
Increased Acute Myocardial Infarction Rates and Cardiovascular Risk Factors among Patients with Human Immunodeficiency Virus Disease
|The Journal of Clinical Endocrinology & Metabolism|2007|1.6k
Cardiovascular Risk and Body-Fat Abnormalities in HIV-Infected Adults
|New England Journal of Medicine|2005|1.1k
Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant
|New England Journal of Medicine|2000|874
Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation
|Genetics in Medicine|2021|766